Jayu.Bo
JAYU.BO operates in the Food & Drug Retailing industry, generating revenue primarily through the retail and distribution of food and drug products.
Business. JAYU.BO operates in the Food & Drug Retailing industry, generating revenue primarily through the retail and distribution of food and drug products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
JAYU.BO operates in the Food & Drug Retailing industry, generating revenue primarily through the retail and distribution of food and drug products.
JAYU.BO maintains a capital structure with a debt-to-equity ratio of 0.64, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.71, suggesting it can cover its short-term obligations with its current assets. However, the company's operating cash flow is negative at -30,479,000 INR, which may signal short-term liquidity challenges.
In terms of profitability, JAYU.BO reports a return on equity (ROE) of 20.29% and a return on assets (ROA) of 10.28%, both of which are strong indicators of efficient use of equity and assets. These figures suggest the company is generating solid returns relative to its equity base and asset base, which is favorable compared to industry norms.
The company's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification in the provided data. This concentration may expose the company to regional economic fluctuations and supply chain disruptions, which could impact its revenue stability.
Looking at the growth trajectory, JAYU.BO has demonstrated a positive free cash flow of 20,166,000 INR, which is a positive sign for reinvestment and shareholder returns. The company's capital expenditure of -10,639,000 INR indicates ongoing investment in its operations, which could support future growth. However, the negative net cash position after subtracting total debt suggests potential liquidity constraints that may need to be managed carefully.
The risk assessment for JAYU.BO highlights a medium liquidity risk, primarily due to the negative net cash position after accounting for total debt. The dilution risk is assessed as low, indicating that the company is not currently facing significant pressure to issue additional shares. The company's financial health is further supported by a strong equity base of 135,706,000 INR, which provides a buffer against financial distress.
Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's financial performance and strategic direction appear to be stable, with no immediate signs of distress or significant operational changes.
- JAYU.BO has a strong return on equity (20.29%) and return on assets (10.28%), indicating efficient use of capital.
- The company's liquidity position is moderate, with a current ratio of 1.71, but it faces a negative operating cash flow of -30,479,000 INR.
- JAYU.BO's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification.
- The company's free cash flow of 20,166,000 INR supports reinvestment and shareholder returns.
- The company's debt-to-equity ratio of 0.64 suggests a moderate reliance on debt financing.
- JAYU.BO's capital expenditure of -10,639,000 INR indicates ongoing investment in its operations.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- JAYU.BO Market data — financials · 2026-05-28